Clinical Trial Update: Oral BBR-012 in the Treatment of Diabetic Foot Ulcers, Proof of Concept Study [Phase 2]

View source ↗

Summary

Phase 2 proof-of-concept trial evaluating oral BBR-012 for treating diabetic foot ulcers; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• BBR-012

Snippet

Sponsor: Bridge BioResearch Ltd. | Conditions: Diabetic Foot Ulcer | Phase 2 | Status: UNKNOWN